Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs
/PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of...
United States Max Darnell Jason Kelly American Society Of Gene Cell Therapy Wisconsin Alumni Research Foundation Ginkgo Cell Therapy Services
Source: prnewswire.com